These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17571573)

  • 61. Antibacterial action of several tannins against Staphylococcus aureus.
    Akiyama H; Fujii K; Yamasaki O; Oono T; Iwatsuki K
    J Antimicrob Chemother; 2001 Oct; 48(4):487-91. PubMed ID: 11581226
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge.
    Wingard JB; Romanowski EG; Kowalski RP; Mah FS; Ling Y; Bilonick RA; Shanks RM
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3788-94. PubMed ID: 21628536
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In Vitro Determination of Minimum Inhibitory Concentration of Aqueous Garlic Extract and Imipenem against Staphylococcus aureus and Escherichia coli.
    Saha SK; Saha S; Akhter SM; Khatun S; Islam MM; Roy P
    Mymensingh Med J; 2016 Jul; 25(3):477-84. PubMed ID: 27612894
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antibacterial Activity of Protocatechuic Acid Ethyl Ester on Staphylococcus aureus Clinical Strains Alone and in Combination with Antistaphylococcal Drugs.
    Miklasińska M; Kępa M; Wojtyczka RD; Idzik D; Zdebik A; Orlewska K; Wąsik TJ
    Molecules; 2015 Jul; 20(8):13536-49. PubMed ID: 26213908
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Concentration-dependent synergy and antagonism between cefoperazone and imipenem against methicillin-resistant Staphylococcus aureus.
    Rand KH; Brown P
    Antimicrob Agents Chemother; 1995 May; 39(5):1173-7. PubMed ID: 7625809
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increasing ofloxacin resistance of bacterial flora from conjunctival sac of preoperative ophthalmic patients in Japan.
    Kurokawa N; Hayashi K; Konishi M; Yamada M; Noda T; Mashima Y
    Jpn J Ophthalmol; 2002; 46(5):586-9. PubMed ID: 12457921
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antimicrobial activity of the new FabI inhibitor afabicin desphosphono against intraosteoblastic Staphylococcus aureus.
    Dyon-Tafani V; Josse J; Dieppois G; Ferry T; Laurent F
    Int J Antimicrob Agents; 2021 May; 57(5):106321. PubMed ID: 33716179
    [No Abstract]   [Full Text] [Related]  

  • 68. Binding properties of antimicrobial agents to lipid membranes using surface plasmon resonance.
    Kinouchi H; Arimoto H; Nishiguchi K; Oka M; Maki H; Kitagawa H; Kamimori H
    Biol Pharm Bull; 2014; 37(8):1383-9. PubMed ID: 25087959
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [In vitro bactericidal effects of ofloxacin on S. aureus].
    Korting HC; Maier W; Schäfer-Korting M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):387-94. PubMed ID: 3218394
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MABTRAINS: Numerous anti-infective modalities ride together.
    van Strijp JAG
    Cell Host Microbe; 2023 May; 31(5):687-688. PubMed ID: 37167949
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A new biotyping method for Streptococcus mutans with the API ZYM system.
    De La Higuera A; Gutiérrez J; Liébana J; Garcia-Mendoza A; Castillo A
    Clin Microbiol Infect; 1999 Feb; 5(2):88-91. PubMed ID: 11856223
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Questionable susceptibility reporting in a multicenter trial.
    Gubbins PO; Bradsher RW
    Antimicrob Agents Chemother; 1995 Apr; 39(4):1012-3. PubMed ID: 7785972
    [No Abstract]   [Full Text] [Related]  

  • 73. Retraction note: Design and formulation technique of a novel drug delivery system for azithromycin and its anti-bacterial activity against Staphylococcus aureus.
    Nirmala MJ; Mukherjee A; Chandrasekaran N
    AAPS PharmSciTech; 2014 Apr; 15(2):511. PubMed ID: 24515271
    [No Abstract]   [Full Text] [Related]  

  • 74. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antimicrobial susceptibility of Staphylococcus aureus isolated from colonized hospital personnel.
    Poiată A; Tuchiluş C; Ambăruş A; Teodor A; Teodorescu I; Luca V; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):723-6. PubMed ID: 17571573
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.
    Wang H; Liu Y; Sun H; Xu Y; Xie X; Chen M
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):226-9. PubMed ID: 18653301
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
    Samra Z; Ofer O; Shmuely H
    Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.